Rockwell Medical, Inc.
RMTI
$1.03
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 21.38% | 22.37% | 24.58% | 13.45% | 14.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.38% | 22.37% | 24.58% | 13.45% | 14.84% |
| Cost of Revenue | 12.14% | 13.12% | 18.38% | 12.42% | 8.98% |
| Gross Profit | 100.87% | 104.59% | 87.97% | 22.89% | 113.54% |
| SG&A Expenses | 18.15% | 5.20% | -4.07% | -13.51% | -19.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.74% | 10.59% | 13.58% | 5.97% | 0.77% |
| Operating Income | 109.12% | 107.17% | 69.25% | 43.30% | 60.26% |
| Income Before Tax | 94.31% | 86.69% | 58.89% | 36.54% | 54.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 94.31% | 86.69% | 58.89% | 36.54% | 54.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 94.31% | 86.69% | 58.89% | 36.54% | 54.83% |
| EBIT | 109.12% | 107.17% | 69.25% | 43.30% | 60.26% |
| EBITDA | 153.35% | 139.30% | 90.62% | 56.87% | 67.75% |
| EPS Basic | 92.38% | 89.78% | 81.29% | 70.77% | 76.95% |
| Normalized Basic EPS | 95.66% | 91.41% | 80.63% | 70.28% | 76.64% |
| EPS Diluted | 90.59% | 88.55% | 80.84% | 70.44% | 76.78% |
| Normalized Diluted EPS | 95.25% | 91.10% | 80.58% | 70.28% | 76.64% |
| Average Basic Shares Outstanding | 45.24% | 75.36% | 125.47% | 135.51% | 116.91% |
| Average Diluted Shares Outstanding | 48.10% | 78.95% | 128.55% | 135.51% | 116.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |